These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38674199)

  • 1.
    Stojkovic Lalosevic M; Coric V; Pekmezovic T; Simic T; Pavlovic Markovic A; Pljesa Ercegovac M
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674199
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
    Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
    Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.
    Stoehlmacher J; Park DJ; Zhang W; Groshen S; Tsao-Wei DD; Yu MC; Lenz HJ
    J Natl Cancer Inst; 2002 Jun; 94(12):936-42. PubMed ID: 12072547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development.
    Stojkovic Lalosevic ML; Coric VM; Pekmezovic TD; Simic TP; Pljesa Ercegovac MS; Pavlovic Markovic AR; Krivokapic ZV
    Pathol Oncol Res; 2019 Oct; 25(4):1579-1587. PubMed ID: 30694518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin.
    Kap EJ; Richter S; Rudolph A; Jansen L; Ulrich A; Hoffmeister M; Ulrich CM; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2014 Jul; 24(7):340-7. PubMed ID: 24842074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.
    Stoehlmacher J; Park DJ; Zhang W; Yang D; Groshen S; Zahedy S; Lenz HJ
    Br J Cancer; 2004 Jul; 91(2):344-54. PubMed ID: 15213713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma.
    Atanaskovic L; Cikota-Aleksic B; Tarabar O; Trimcev J; Zivanovic-Ivic A; Marjanovic S; Magic Z
    J BUON; 2016; 21(6):1459-1465. PubMed ID: 28039708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients.
    Jones BA; Christensen AR; Wise JP; Yu H
    Cancer Epidemiol; 2009 Oct; 33(3-4):249-56. PubMed ID: 19748847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
    Abbas M; Kushwaha VS; Srivastava K; Banerjee M
    PLoS One; 2015; 10(11):e0142501. PubMed ID: 26571237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients.
    Jun L; Haiping Z; Beibei Y
    Swiss Med Wkly; 2009 Dec; 139(49-50):724-8. PubMed ID: 20047135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
    Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
    Etienne-Grimaldi MC; Milano G; Maindrault-Goebel F; Chibaudel B; Formento JL; Francoual M; Lledo G; André T; Mabro M; Mineur L; Flesch M; Carola E; de Gramont A
    Br J Clin Pharmacol; 2010 Jan; 69(1):58-66. PubMed ID: 20078613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
    Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
    Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer.
    Rodrigues-Fleming GH; Fernandes GMM; Russo A; Biselli-Chicote PM; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
    World J Gastroenterol; 2018 Oct; 24(39):4462-4471. PubMed ID: 30356976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.
    Chen YC; Tzeng CH; Chen PM; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Wang WS
    Cancer Sci; 2010 Feb; 101(2):530-5. PubMed ID: 19922504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients.
    Kweekel DM; Gelderblom H; Antonini NF; Van der Straaten T; Nortier JW; Punt CJ; Guchelaar HJ
    Eur J Cancer; 2009 Mar; 45(4):572-8. PubMed ID: 19084393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.
    Albarakati N; Khayyat D; Dallol A; Al-Maghrabi J; Nedjadi T
    BMC Cancer; 2019 Oct; 19(1):991. PubMed ID: 31646988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.